Combination of an urolithin with an immunotherapy treatment
AU2026205471A1Pending Publication Date: 2026-07-30AMAZENTIS SA
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- AMAZENTIS SA
- Filing Date
- 2026-07-09
- Publication Date
- 2026-07-30
Smart Images
Figure 00000044_0000 
Figure 00000045_0000 
Figure 00000045_0001
Abstract
Abstract The invention relates to combinations of urolithins with therapeutic agents, particularly combinations of urolithins with immunotherapy treatments, such as immune checkpoint blockage therapies, such as PD-1 antagonists. The invention also relates to pharmaceutical compositions comprising said combinations, processes of preparing said pharmaceutical compositions and methods of treating diseases with said compositions. In one embodiment, the immune checkpoint blockage therapy is selected from an anti-PD-1 antibody, an anti-PD- L1 antibody, an anti-CTLA4 antibody or a fusion protein. Abstract 20 26 20 54 71 09 J ul 2 02 6 A b s t r a c t 2 0 2 6 2 0 5 4 7 1 0 9 J u l 2 0 2 6
Need to check novelty before this filing date? Find Prior Art